Danaher To Buy Phenomenex - Quick Facts

(RTTNews) - Phenomenex Inc., a privately held manufacturer and distributor of high-value consumables for the separation sciences, announced it has signed a definitive agreement to be acquired by Danaher Corp. (DHR). Phenomenex will operate as a standalone operating company, retaining the Phenomenex brand. Phenomenex has more than 7,000 products supporting a broad diversity of applications in drug discovery and development, clinical research, forensic toxicology, petrochemical, environmental analysis and food safety.

Dan Daniel, Executive Vice President, Danaher, said: "Phenomenex is a strong business characterized by high growth rates and margins and excellent growth prospects driven by increasing analytical testing needs in the health, research and environmental segments. The Danaher Business System (DBS) has a strong track record of helping businesses rapidly scale operations and create long-term customer value. We look forward to supporting the Phenomenex team in leveraging DBS tools for growth and welcoming them to our Life Sciences team."